These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36332080)

  • 1. Validity and reliability of the Turkish version of the ALBA screening instrument for Lewy body dementia in older adults.
    Kaya D; Yesil Gurel BH; Akpinar Soylemez B; Dost FS; Dokuzlar O; Mutlay F; Ates Bulut E; Petek K; Golimstok AB; Isik AT
    Appl Neuropsychol Adult; 2022 Nov; ():1-6. PubMed ID: 36332080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALBA Screening Instrument (ASI): A brief screening tool for Lewy Body Dementia.
    Garcia Basalo MM; Fernandez MC; Ojea Quintana M; Rojas JI; Garcia Basalo MJ; Bogliotti E; Campora N; Fernandez M; Berrios W; Cristiano E; Golimstok A
    Arch Gerontol Geriatr; 2017; 70():67-75. PubMed ID: 28088604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Turkish version of the Lewy body composite risk score.
    Mutlay F; Kaya D; Ates Bulut E; Akpınar Söylemez B; Öntan MS; Isık AT
    Appl Neuropsychol Adult; 2023 May; ():1-7. PubMed ID: 37183974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater Variability in Cognitive Decline in Lewy Body Dementia Compared to Alzheimer's Disease.
    Giil LM; Aarsland D
    J Alzheimers Dis; 2020; 73(4):1321-1330. PubMed ID: 31903991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perception of Fragmented Letters by Patients With Pathologically Confirmed Dementia With Lewy Bodies or Alzheimer Disease.
    Salmon DP; Smirnov DS; Coughlin DG; Hamilton JM; Landy KM; Filoteo JV; Hiniker A; Hansen LA; Galasko D
    Neurology; 2022 Nov; 99(18):e2034-e2043. PubMed ID: 36028327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Korean Version of the Lewy Body Composite Risk Score (K-LBCRS).
    Ryu HJ; Kim M; Moon Y; Choi Y; Han JY; Galvin JE; Han SH
    J Alzheimers Dis; 2017; 55(4):1395-1401. PubMed ID: 27834773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
    Ben Jemaa S; Attia Romdhane N; Bahri-Mrabet A; Jendli A; Le Gall D; Bellaj T
    J Alzheimers Dis; 2017; 60(1):11-21. PubMed ID: 28505978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Drawing Process Differentiate Alzheimer's Disease and Dementia with Lewy Bodies.
    Yamada Y; Kobayashi M; Shinkawa K; Nemoto M; Ota M; Nemoto K; Arai T
    J Alzheimers Dis; 2022; 90(2):693-704. PubMed ID: 36155515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and Validity of the Turkish Version of the Addiction Severity Index in Male Alcohol Dependents.
    Demirbaş H; Özgür Ilhan İ; Doğan YB; Canatan A
    Noro Psikiyatr Ars; 2014 Sep; 51(3):216-221. PubMed ID: 28360629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Sinhala version of the Montreal Cognitive Assessment in screening for dementia.
    Karunaratne S; Hanwella R; de Silva V
    Ceylon Med J; 2011 Dec; 56(4):147-53. PubMed ID: 22298207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
    Ozdilek B; Kenangil G
    Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese patients with Lewy body dementia had shorter survival and developed complications earlier than those with Alzheimer's disease.
    Shea YF; Lee SC; Shum ACK; Chiu PK; Chu LW; Chan HWF
    Singapore Med J; 2020 Oct; 61(10):551-558. PubMed ID: 31489427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index trajectories and associations with cognitive decline in people with Lewy body dementia and Alzheimer's disease.
    Borda MG; Jaramillo-Jimenez A; Giil LM; Tovar-Rios DA; Soennesyn H; Aarsland D
    Health Sci Rep; 2022 May; 5(3):e590. PubMed ID: 35509416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
    Daniele S; Baldacci F; Piccarducci R; Palermo G; Giampietri L; Manca ML; Pietrobono D; Frosini D; Nicoletti V; Tognoni G; Giorgi FS; Lo Gerfo A; Petrozzi L; Cavallini C; Franzoni F; Ceravolo R; Siciliano G; Trincavelli ML; Martini C; Bonuccelli U
    J Alzheimers Dis; 2021; 80(2):885-893. PubMed ID: 33579836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the Montreal Cognitive Assessment Thai Version to Discriminate Amnestic Mild Cognitive Impairment from Alzheimer's Disease and Healthy Controls: Machine Learning Results.
    Hemrungrojn S; Tangwongchai S; Charoenboon T; Panasawat M; Supasitthumrong T; Chaipresertsud P; Maleevach P; Likitjaroen Y; Phanthumchinda K; Maes M
    Dement Geriatr Cogn Disord; 2021; 50(2):183-194. PubMed ID: 34325427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Alzheimer's and Lewy body disease have discrete pathological signatures of gait?
    Mc Ardle R; Galna B; Donaghy P; Thomas A; Rochester L
    Alzheimers Dement; 2019 Oct; 15(10):1367-1377. PubMed ID: 31548122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and concurrent validity of Alzheimer's disease assessment scale - Cognitive subscale, Chinese version (ADAS-Cog-C) among Chinese community-dwelling older people population.
    Jiang Y; Yang H; Zhao J; Wu Y; Zhou X; Cheng Z
    Clin Neuropsychol; 2020 Dec; 34(sup1):43-53. PubMed ID: 32279575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment.
    Fujiwara Y; Suzuki H; Yasunaga M; Sugiyama M; Ijuin M; Sakuma N; Inagaki H; Iwasa H; Ura C; Yatomi N; Ishii K; Tokumaru AM; Homma A; Nasreddine Z; Shinkai S
    Geriatr Gerontol Int; 2010 Jul; 10(3):225-32. PubMed ID: 20141536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy.
    Chouliaras L; Thomas A; Malpetti M; Donaghy P; Kane J; Mak E; Savulich G; Prats-Sedano MA; Heslegrave AJ; Zetterberg H; Su L; Rowe JB; O'Brien JT
    J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):651-658. PubMed ID: 35078917
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.